loading
Precedente Chiudi:
$6.365
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$15.16M
Reddito:
$74,000
Utile/perdita netta:
$-13.43M
Rapporto P/E:
0.00
EPS:
-9.4
Flusso di cassa netto:
$-10.54M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
Value
$0.00
$0.00
Intervallo di 1 settimana:
Value
$0.00
$0.00
Portata 52W:
Value
$0.00
$19.87

Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile

Name
Nome
Cyclacel Pharmaceuticals Inc
Name
Telefono
908-517-7330
Name
Indirizzo
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Name
Dipendente
12
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
CYCC's Discussions on Twitter

Confronta CYCC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CYCC
Cyclacel Pharmaceuticals Inc
0.00 15.16M 74,000 -13.43M -10.54M -9.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.59 117.69B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
768.00 83.72B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
796.00 48.79B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
370.91 52.62B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
333.99 37.39B 4.98B 69.59M 525.67M 0.5197

Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-07-18 Ripresa Oppenheimer Outperform
2020-04-27 Ripresa ROTH Capital Buy
2018-09-07 Iniziato Ladenburg Thalmann Buy
2015-10-16 Iniziato H.C. Wainwright Buy
2010-02-04 Iniziato Roth Capital Buy
2009-10-28 Iniziato Merriman Buy
2008-08-12 Iniziato Piper Jaffray Buy
2008-03-12 Reiterato Cantor Fitzgerald Buy
2008-03-12 Reiterato Collins Stewart Buy
2008-03-12 Reiterato Needham & Co Buy
2007-11-27 Reiterato Cantor Fitzgerald Buy
2007-08-10 Reiterato Cantor Fitzgerald Buy
2007-06-04 Reiterato Needham & Co Buy
2007-04-23 Iniziato Lazard Capital Buy
2007-04-10 Iniziato Cantor Fitzgerald Buy
Mostra tutto

Cyclacel Pharmaceuticals Inc Borsa (CYCC) Ultime notizie

pulisher
Jan 11, 2026

CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com

Jan 11, 2026
pulisher
Jan 08, 2026

Is Cyclacel Pharmaceuticals Inc. stock a bargain at current levels2025 Earnings Impact & Daily Profit Focused Stock Screening - ulpravda.ru

Jan 08, 2026
pulisher
Jan 06, 2026

Cyclacel stock dips after trimming 270% surge amid volatility concerns - MSN

Jan 06, 2026
pulisher
Jan 06, 2026

Why Cyclacel Pharmaceuticals Inc. stock remains on buy lists2026 world cup usa national team semifinals young talents high defensive line match prediction preview - ulpravda.ru

Jan 06, 2026
pulisher
Dec 30, 2025

PPL Corporation PP9 Stock Analysis and ForecastVolatility Index Analysis & Your Free Entry to Smart Investing Starts Here - earlytimes.in

Dec 30, 2025
pulisher
Dec 27, 2025

Cyclacel Pharmaceuticals Inc. (CYCC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 27, 2025
pulisher
Dec 23, 2025

Can Cyclacel Pharmaceuticals Inc. stock hit analyst price targetsVolatility Trading Techniques & Double Or Triple Investment - Bollywood Helpline

Dec 23, 2025
pulisher
Dec 21, 2025

Published on: 2025-12-21 23:05:19 - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Published on: 2025-12-20 22:06:08 - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Can Cyclacel Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Portfolio Review & Accurate Entry/Exit Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Gap Down: Can Cyclacel Pharmaceuticals Inc. stock hit analyst price targetsWeekly Gains Report & Risk Managed Investment Signals - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Cyclacel Pharmaceuticals Inc. stock hit record highs againOptions Play & Verified Momentum Stock Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Published on: 2025-12-19 13:13:56 - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

How strong is Cyclacel Pharmaceuticals Inc. stock balance sheet2025 Analyst Calls & Long-Term Investment Growth Plans - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Layoff Watch: Is Cyclacel Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 EndofMonth & Daily Stock Trend Reports - Улправда

Dec 18, 2025
pulisher
Dec 11, 2025

Inflation Data: How strong is Cyclacel Pharmaceuticals Inc. stock balance sheet2025 Volume Leaders & Growth-Oriented Investment Plans - moha.gov.vn

Dec 11, 2025
pulisher
Nov 29, 2025

Market Review: Can Cyclacel Pharmaceuticals Inc. stock hit analyst price targetsStock Surge & Verified Momentum Stock Ideas - moha.gov.vn

Nov 29, 2025
pulisher
Nov 29, 2025

Cyclacel Pharmaceuticals Inc Stock Analysis and ForecastResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in

Nov 29, 2025
pulisher
Nov 24, 2025

Cyclacel Pharmaceuticals (BGMS) Stock Chart and Price History 2025 - MarketBeat

Nov 24, 2025
pulisher
Nov 23, 2025

Cyclacel Pharmaceuticals (BGMS) Stock Trends and Sentiment 2025 - MarketBeat

Nov 23, 2025
pulisher
Nov 22, 2025

Cyclacel Pharmaceuticals (BGMS) Competitors and Alternatives 2025 - MarketBeat

Nov 22, 2025
pulisher
Nov 21, 2025

Should I hold or sell Cyclacel Pharmaceuticals Inc. stock in 20252025 Big Picture & Real-Time Volume Surge Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Cyclacel Pharmaceuticals (NASDAQ:BGMS) Rating Increased to Hold at Wall Street Zen - Defense World

Nov 21, 2025
pulisher
Nov 21, 2025

Cyclacel Pharmaceuticals (BGMS) Stock Price, News & Analysis - MarketBeat

Nov 21, 2025
pulisher
Nov 21, 2025

How Cyclacel Pharmaceuticals Inc. stock trades during market volatilityJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Is Cyclacel Pharmaceuticals Inc. stock in correction or buying zoneJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Cyclacel Pharmaceuticals Inc. stock resilient to inflation2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Visual analytics tools that track Cyclacel Pharmaceuticals Inc. performance2025 Biggest Moves & Smart Money Movement Tracker - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Cyclacel Pharmaceuticals Inc. stock deliver surprise earnings beatEntry Point & Risk Managed Investment Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Cyclacel Pharmaceuticals Inc. stock attractive for passive investorsWeekly Risk Summary & High Yield Equity Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Cyclacel Pharmaceuticals Inc. stock is popular among millennialsPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Cyclacel Pharmaceuticals Inc. stock reach all time highs in 2025 - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

Order flow analysis tools used on Cyclacel Pharmaceuticals Inc.Portfolio Value Summary & Real-Time Stock Entry Alerts - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Published on: 2025-11-16 16:56:09 - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Evaluating Cyclacel Pharmaceuticals Inc. with trendline analysisJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

What to do if you’re stuck in Cyclacel Pharmaceuticals Inc.Weekly Risk Summary & Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Can Cyclacel Pharmaceuticals Inc. stock resist sector downturnsGap Up & High Yield Stock Recommendations - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Can trapped investors hope for a rebound in Cyclacel Pharmaceuticals Inc.Market Risk Report & Daily Stock Momentum Reports - newser.com

Nov 15, 2025

Cyclacel Pharmaceuticals Inc Azioni (CYCC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$106.33
price down icon 0.51%
$33.95
price down icon 0.90%
$117.17
price down icon 1.24%
$102.18
price up icon 2.33%
$167.72
price down icon 4.69%
biotechnology ONC
$333.99
price down icon 1.15%
Capitalizzazione:     |  Volume (24 ore):